pattismith
Senior Member
- Messages
- 3,884
@andyguitar
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action
lHuajuanJiangaJieLiaLinWangaShengjuWangaXinNieaYiChenaQiangFubMaoyuanJiangaChaomeiFuaYaoHea
https://doi.org/10.1016/j.jep.2020.112913Get rights and content
Abstract
Ethnopharmacological relevance
Paeoniae Radix Alba (PRA), called baishao in China), the root of Paeonia lactiflora Pall., has shown a rich medicinal value for more than 2000 years.
PRA is used in local medicine and traditional medicine for autoimmune diseases associated with inflammation.
At present, total glucosides of paeony (TGP), the main active ingredient of PRA, has been developed into a preparation for the treatment of autoimmune diseases, as TGP exhibits the effect of regulating immunity, anti-inflammatory, and analgesic effects.
;;;
Results
Approximately 15 compounds have been identified in TGP, of which paeoniflorin and albiflorin are the most common constituents.
In recent years, studies have found that TGP and its main chemical components are effective in the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, oral lichen planus, and Sjogren's syndrome.
TGP has a variety of pharmacological effects related to PRA traditional effects, including anti-organ-damage, anti-inflammatory, analgesic, antioxidant, cardiovascular, and nervous-system protection.
Previously published reports on TGP treatment of autoimmune diseases have shown that TGP regulates intracellular pathways, such as the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathways.
However, there is no standardized preparation method for TGP, and there is insufficient quality control of formulations.
Many related pharmacological studies have not tested TGP components, and the validity of such pharmacological results requires further verification.
Conclusions
Modern pharmacological research on TGP is based on the traditional usage of PRA, and its folk medicinal value in the treatment of autoimmune diseases has now been verified.
In particular, TGP has been developed into a formulation used clinically for the treatment of autoimmune diseases.
The combination of TGP capsules and chemicals to treat autoimmune diseases has the effect of increasing efficacy and reducing toxicity.
Based on further research on its preparation, quality control, and mechanisms of action, TGP is expected to eventually play a greater role in the treatment of autoimmune diseases.
Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action
lHuajuanJiangaJieLiaLinWangaShengjuWangaXinNieaYiChenaQiangFubMaoyuanJiangaChaomeiFuaYaoHea
https://doi.org/10.1016/j.jep.2020.112913Get rights and content
Abstract
Ethnopharmacological relevance
Paeoniae Radix Alba (PRA), called baishao in China), the root of Paeonia lactiflora Pall., has shown a rich medicinal value for more than 2000 years.
PRA is used in local medicine and traditional medicine for autoimmune diseases associated with inflammation.
At present, total glucosides of paeony (TGP), the main active ingredient of PRA, has been developed into a preparation for the treatment of autoimmune diseases, as TGP exhibits the effect of regulating immunity, anti-inflammatory, and analgesic effects.
;;;
Results
Approximately 15 compounds have been identified in TGP, of which paeoniflorin and albiflorin are the most common constituents.
In recent years, studies have found that TGP and its main chemical components are effective in the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, oral lichen planus, and Sjogren's syndrome.
TGP has a variety of pharmacological effects related to PRA traditional effects, including anti-organ-damage, anti-inflammatory, analgesic, antioxidant, cardiovascular, and nervous-system protection.
Previously published reports on TGP treatment of autoimmune diseases have shown that TGP regulates intracellular pathways, such as the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathways.
However, there is no standardized preparation method for TGP, and there is insufficient quality control of formulations.
Many related pharmacological studies have not tested TGP components, and the validity of such pharmacological results requires further verification.
Conclusions
Modern pharmacological research on TGP is based on the traditional usage of PRA, and its folk medicinal value in the treatment of autoimmune diseases has now been verified.
In particular, TGP has been developed into a formulation used clinically for the treatment of autoimmune diseases.
The combination of TGP capsules and chemicals to treat autoimmune diseases has the effect of increasing efficacy and reducing toxicity.
Based on further research on its preparation, quality control, and mechanisms of action, TGP is expected to eventually play a greater role in the treatment of autoimmune diseases.